Get the Stockscreener App
12.22
1.92%
0.23
Obsidian Therapeutics, Inc. Common Stock Stock (OBX) Forecast
The Obsidian Therapeutics, Inc. Common Stock (OBX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $4.6252, representing a -62.15% decrease from the current price of $12.22. The highest analyst price target is $8.6543, and the lowest is $0.5962.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month OBX Price Target
Average 17.37
(+42.11% Upside)
Is Obsidian Therapeutics, Inc. Common Stock (OBX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 32.84 | Neutral |
| STOCH(9,6) | 19.00 | Buy |
| STOCHRSI(14) | 79.72 | Neutral |
| MACD(12,26) | -1.763 | Buy |
| ADX(14) | 24.81 | Neutral |
| William %R | -88.01 | Buy |
| CCI(14) | -36.17 | Neutral |
Buy: 3
Sell: 0
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
12.94
Sell
|
12.97
Sell
|
| MA20 |
14.11
Sell
|
14.15
Sell
|
| MA50 |
17.92
Sell
|
18.12
Sell
|
| MA100 |
9.3025
Buy
|
0.00
Buy
|
| MA200 |
4.6512
Buy
|
0.00
Buy
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, OBX could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 6 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on OBX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 32.84 indicates that OBX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 19 indicates that OBX is oversold. This indicates that OBX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 79.72 indicates that OBX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.81 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -36.17 indicates that OBX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term OBX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Obsidian Therapeutics, Inc. Common Stock financial reports and earnings history, Obsidian Therapeutics, Inc. Common Stock (OBX) stock could reach $173.30 by 2030, $775.15 by 2040 and $1,291.21 by 2050. See the projected annual prices until 2050 of the Obsidian Therapeutics, Inc. Common Stock stock below:
- Obsidian Therapeutics, Inc. Common Stock (OBX) is expected to reach an average price of $436.61 in 2035, with a high prediction of $469.55 and a low estimate of $233.83. This indicates an $3,473% rise from the last recorded price of $12.22.
- Obsidian Therapeutics, Inc. Common Stock (OBX) stock is projected to chart a bullish course in 2040, with an average price target of $666.54, representing an $5,355% surge from its current level. The forecast ranges from a conservative $668.53 to a sky-high $775.15.
- Our analysts predict Obsidian Therapeutics, Inc. Common Stock (OBX) to jump 7,038% by 2045, soaring from $872.93 to an average price of $872.26, potentially reaching $1,043.39. While $872.93 is the low estimate, the potential upside is significant.
- Obsidian Therapeutics, Inc. Common Stock (OBX) stock is expected to climb by 2050, reaching an average of $1,050.18, a $8,494% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1,291.21 and $1,051.00, respectively, highlighting the market's uncertainty.
Obsidian Therapeutics, Inc. Common Stock Stock (OBX) Year by Year Forecast
Obsidian Therapeutics, Inc. Common Stock Stock (OBX) Price Forecast for 2026
The predicted value for Obsidian Therapeutics, Inc. Common Stock (OBX) in 2026 is set at an average of $25.28. Estimates vary from a peak of $49.97 to a trough of $0.5962, indicating an +106.90% surge from the present price of $12.22.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $6.4385 | $0.5962 | $8.6543 | -47.31% |
| December, 2026 | $4.8409 | $2.1047 | $8.2896 | -60.39% |
Obsidian Therapeutics, Inc. Common Stock Stock (OBX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Obsidian Therapeutics, Inc. Common Stock (OBX) is $25.32, with a high forecast of $47.54 and a low forecast of $3.0959. This indicates an +107.18% increase from the last price of $12.22.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $11.48 | $3.974 | $19.41 | -6.02% |
| February, 2027 | $7.2091 | $7.8791 | $7.3453 | -41.01% |
| March, 2027 | $3.9083 | $4.4283 | $3.4294 | -68.02% |
| April, 2027 | $26.11 | $3.0959 | $4.8807 | +113.67% |
| May, 2027 | $16.28 | $17.10 | $20.01 | +33.26% |
| June, 2027 | $12.66 | $13.18 | $13.13 | +3.58% |
| July, 2027 | $40.74 | $10.54 | $19.51 | +233.37% |
| August, 2027 | $27.65 | $28.47 | $33.57 | +126.24% |
| September, 2027 | $21.41 | $21.93 | $23.84 | +75.18% |
| October, 2027 | $55.36 | $17.98 | $34.13 | +353.07% |
| November, 2027 | $39.01 | $39.83 | $47.54 | +219.21% |
| December, 2027 | $30.16 | $30.68 | $34.54 | +146.77% |
Obsidian Therapeutics, Inc. Common Stock Stock (OBX) Price Forecast for 2028
In 2028, Obsidian Therapeutics, Inc. Common Stock (OBX) is projected to reach an average price of $64.43, with a high projection of $103.43 and a low estimate of $25.42. This indicates an +427.25% rise from the last price of $12.22.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $63.94 | $25.42 | $61.51 | +423.26% |
| February, 2028 | $50.37 | $51.19 | $58.02 | +312.18% |
| March, 2028 | $38.90 | $39.42 | $45.25 | +218.37% |
| April, 2028 | $84.62 | $32.87 | $63.39 | +592.46% |
| May, 2028 | $61.73 | $62.55 | $75.49 | +405.16% |
| June, 2028 | $47.65 | $48.17 | $55.96 | +289.97% |
| July, 2028 | $91.89 | $40.31 | $89.46 | +651.97% |
| August, 2028 | $73.09 | $73.91 | $84.59 | +498.13% |
| September, 2028 | $56.40 | $56.92 | $66.67 | +361.56% |
| October, 2028 | $105.86 | $47.75 | $103.43 | +766.32% |
| November, 2028 | $84.45 | $85.27 | $97.91 | +591.11% |
| December, 2028 | $65.15 | $65.67 | $77.38 | +433.16% |
Obsidian Therapeutics, Inc. Common Stock Stock (OBX) Price Forecast for 2029
The 2029 price forecast for Obsidian Therapeutics, Inc. Common Stock Stock (OBX) is $107.26 on average, with a high prediction of $159.33 and a low estimate of $55.20. This represents an +777.77% increase from the previous price of $12.22.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $119.84 | $55.20 | $117.41 | +880.67% |
| February, 2029 | $95.81 | $96.63 | $111.23 | +684.08% |
| March, 2029 | $73.90 | $74.42 | $88.09 | +504.76% |
| April, 2029 | $133.81 | $62.64 | $131.38 | +995.03% |
| May, 2029 | $107.18 | $108.00 | $124.55 | +777.06% |
| June, 2029 | $82.65 | $83.17 | $98.79 | +576.35% |
| July, 2029 | $147.79 | $70.08 | $145.36 | +1,109% |
| August, 2029 | $118.54 | $119.36 | $137.87 | +870.03% |
| September, 2029 | $91.40 | $91.92 | $109.50 | +647.95% |
| October, 2029 | $161.76 | $77.53 | $159.33 | +1,224% |
| November, 2029 | $129.90 | $130.72 | $151.19 | +963.01% |
| December, 2029 | $92.25 | $93.18 | $120.21 | +654.90% |
Obsidian Therapeutics, Inc. Common Stock Stock (OBX) Price Forecast for 2030
Obsidian Therapeutics, Inc. Common Stock Stock (OBX) is expected to reach an average price of $150.10 in 2030, with a high forecast of $215.23 and a low forecast of $84.97. This signifies an +1,128% surge from the last price of $12.22.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $175.73 | $84.97 | $173.30 | +1,338% |
| February, 2030 | $141.26 | $142.08 | $164.52 | +1,056% |
| March, 2030 | $108.90 | $109.42 | $130.92 | +791.14% |
| April, 2030 | $189.71 | $92.41 | $187.28 | +1,452% |
| May, 2030 | $152.62 | $153.44 | $177.84 | +1,149% |
| June, 2030 | $117.65 | $118.17 | $141.63 | +862.74% |
| July, 2030 | $203.68 | $99.85 | $201.25 | +1,567% |
| August, 2030 | $163.98 | $164.80 | $191.16 | +1,242% |
| September, 2030 | $116.54 | $117.47 | $152.34 | +853.66% |
| October, 2030 | $217.66 | $107.30 | $215.23 | +1,681% |
| November, 2030 | $175.35 | $176.17 | $204.48 | +1,335% |
| December, 2030 | $124.63 | $125.56 | $163.04 | +919.91% |
6.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):